Several revolutionary therapies are now available in the Britain for controlling glucose intolerance. Saxenda, Metformin, and Jardiance represent different approaches, with copyright and Jardiance being injectable GLP-1 receptor activators primarily aimed at slimming alongside sugar levels contro